SUMMARY

• Please refer to local prescribing information for storage and stability information.
• Janssen cannot recommend any practices, procedures, or storage conditions that deviate from product labeling and are not approved by the regulatory agencies.

PRODUCT LABELING

How Supplied/Storage and Handling

TECVAYLI injection is a sterile, preservative-free, clear to slightly opalescent, colorless to light yellow solution supplied as follows:¹

• One 30 mg/3 mL (10 mg/mL) single-dose vial in a carton.
• One 153 mg/1.7 mL (90 mg/mL) single-dose vial in a carton.
• Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
• Do not freeze.

Storage of Prepared Dosing Syringe

If the prepared dosing syringe(s) of TECVAYLI is not used immediately, store syringe(s) at 2°C to 8°C (36°F to 46°F) or at ambient temperature 15°C to 30°C (59°F to 86°F) for a maximum of 20 hours. Discard syringe(s) after 20 hours, if not used.¹

Literature Search

A literature search of MEDLINE^®, Embase, BIOSIS Previews^®, and Derwent Drug File databases (and/or other resources, including internal/external databases) was conducted on 13 August 2024.